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Running title: Bacterial vaginosis and women with vaginal symptoms   
Abstract 
This is a prospective study of 297 Consecutive High Vaginal Swab (HVS) specimen from patients with vaginal 
symptoms at the laboratory of Butare University Teaching Hospital, South Province, Rwanda. The aim of the 
study was to evaluate the prevalence of bacterial vaginosis and the role of some micro-organisms and laboratory 
indices associated with it. The age range was 16-57 years with a mean of 30.8 years. The overall prevalence of 
bacterial vaginosis was 17.8% and the highest percentage of 52.8 % (28) found in the age group of 21-30 years 
compared with the lowest percentage of 1.9% (1) in the age group less than 20 years. Almost half of patients with 
trichomoniasis were found to have bacterial vaginosis (P<0.05). The demonstration Clue cells in wet mount was 
found in significantly higher numbers (90.5%) in women with bacterial vaginosis (P<0.001, positive predictive 
value 90.4%) while low sensitivity and positive predictive value were seen for vaginal discharge for detecting 
infection with bacterial vaginosis ( p> 0.05, positive predictive value 26.0%). Bacterial vaginosis is common among 
women with vaginal symptoms in Rwanda as showed by gram stain examination. Further research into this 
pathology in other Rwandan women populations is needed. 
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Introduction  
Vaginal symptoms are among  the most 
common reasons of visits in clinical medicine, 
and occur frequently in women during their 
reproductive health, resulting very often in 
consulting an obstetrician or gynecologist or not 
(1). Bacterial vaginosis (BV) is the most common 
cause of vaginal discharge among women in 
reproductive age with a prevalence of 9-37%, 
depending on the population studied (2, 3). The 
prevalence of vaginal infections, particularly BV, 
is high in many countries in Sub-Saharan Africa. 
For example, 20% to 50% of women of 
reproductive age are affected in Zimbabwe (4). 
It ‘s characterized by a disorder of the vaginal  
ecosystem characterized by a change in the 
vaginal flora from the normally predominant 
lactobacillus to one dominated by sialidase-
enzyme-producing organisms including 
Gardnerella vagonalis, Mobiluncus spp., Prevotella 
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bivia, bacteroides spp., Peptostreptococcus spp., 
Ureaplasma urealyticum, and Mycoplasma hominis 
(5).  All these organisms may have a synergistic 
role in producing the symptoms of BV. The 
condition is although common especially in low 
settings but under diagnosed. This may be due 
to confusion over its complex polymicrobial 
nature (6).  
 
The two most widely accepted methods for the 
diagnosis of bacterial vaginosis, Amsel’s 
composite criteria (7) and Nugent’s Gram stain 
evaluation of bacterial morphotypes (8), are not 
used sufficiently in routine practice (9), mostly 
in low income countries. Although the diagnosis 
of BV by Amsel criteria is simple, it is relatively 
insensitive and not easily subjected to quality 
control, and the apparent complexity of the 
latter may have limited its routine application 
by clinical laboratories. As a consequence, 
surveillance studies on BV are mostly based on 
specialist clinic setting. Its prevalence in 
developed communities has been well 
documented as leading cause of vaginal 
discharge (10), whilst reports on the prevalence 
of BV from developing communities are scarce. 
Authors are not aware of other studies on this 
topic undertaken in Rwanda. The aim of our 
study was to evaluate the prevalence of BV 
among women who presented with vaginal 
symptoms at the Butare University Teaching 
Hospital, a tertiary health facility in South 
province, Rwanda, and to discuss the role of 
some micro-organisms and laboratory indices 
associated with BV. 
 
Materials and methods 
The study was conducted at the unit of 
microbiology (department of medical biology), 
Butare University Teaching Hospital, South 
Province, Rwanda, from March to December 
2007. A total of 296 Consecutive High Vaginal 
Swab (HVS) specimen from patients (aged 16 to 
57 years) with vaginal symptoms, who were 
referred to our laboratory, were included in the 
study. Almost all the patients were symptomatic 
and complained of one or more of the following 
symptoms: vaginal discharge, pruritus, and 
lower abdominal pain. Of 296 high vaginal 
swabs, clinical data on symptoms were available 
for 117 patients. All specimens were taken in 
patients who were already undergoing 
examination and the study was approved by the 
Butare University Teaching Hospital. The study 
was classified as human harm free since it is a 
laboratory-based study and all samples were 
analyzed anonymously to assure the patient 
confidentiality. A sterile cotton tipped swab was 
inserted in the posterior vaginal fornix at the 
time of speculum examination, then two swaps 
were taken, the first swap was rolled on a clean 
slide then a drop of isotonic saline was added 
and the slide was examined microscopically (X 
400) for the presence of clue cells and 
Trichomonas vaginalis.  A second swab of 
secretions was fixed by flame and Gram staining 
of the slide was performed for microscopic 
examination. The slide was examined under oil 
immersion microscopy (X 1000).  Diagnosis of 
bacterial vaginosis was determined according to 
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a morphological scoring system(8), based on the 
proportions of lactobacilli relative to gram-
negative anaerobes. Each slide was read by 2 
independent technicians and was evaluated by 
another when discrepancies arose. The presence 
of yeast was done by slide smear examination of 
gram stain.  
Data processing and statistical analysis were 
performed using SPSS software (version 15.0). 
The results were expressed as percentage, with 
significance at 5% 
 
Results 
  A prospective study of consecutive 297 high 
vaginal swabs from women with vaginal 
symptoms was studied over the 10-month 
period for bacterial vaginosis; the age range was 
16-57 years with a mean of 30.8 years. The 
overall prevalence of bacterial vaginosis was 
17.8% and the highest percentage of 52.8 % (28) 
found in the age group of 21-30 years compared 
with the lowest percentage of 1.9% (1) in the age 
group less than 20 years (Table 1). Yeasts were 
present in samples from 83 (28%) patients and T. 
vaginalis was detected in samples from 11 (3.7%) 
patients.  
Table 2 shows the distribution of T. vaginalis 
infection and the presence of yeast on gram stain 
over the categories of patients with and without 
bacterial vaginosis.  Almost half of patients with 
vaginal trichomoniasis were found to have 
bacterial vaginosis (P<0.05) while only few cases 
with yeasts were associated with bacterial 
vaginosis.  
Of 296 high vaginal swabs, clinical data on 
symptoms reported were available and accurate 
for 117 patients, and only these data were 
analyied further.  Most common symptoms 
identified was vaginal discharge (39.3%) 
followed by pruritus (31.6%), combination of 
vaginal discharge and pruritis (22.2%) and lower 
abdominal pain (6.8%). Table 3 shows a non-
significant trend of a lower rate of symptoms in 
women with negative result compared to 
women with an infectious vaginal agent. A high 
rate of vaginal discharge was found in women 
with Trichomonas vaginalis than in bacterial 
vaginosis or in the absence of pathogen, 
although not to a significant extent. The 
demonstration Clue cells in wet mount was 
found in significantly higher numbers (90.5%) in 
women with bacterial vaginosis (P<0.001, 
positive predictive value 90.4%) while low 
sensitivity and positive predictive value were 
seen for vaginal discharge for detecting infection 
with bacterial vaginosis ( p> 0.05, positive 









TABLE 1:  AGE DISTRIBUTION OF PATIENTS WITH BACTERIAL VAGINOSIS 
AGE GROUP (YEARS) BV (%) I (%) N (%) 
16-20 1 (1.9) 4 (4.9) 9 (5.6) 
21-30 28 (52.8) 38 (46.3) 94 (58.4) 
31-40 18 (34) 28 (34.1) 36 (22.4) 
> 40 6 (11.3) 12 (14.6) 22 (13.7) 
Total 53 (100) 82 (100) 161 (100) 
  
BV, bacterial vaginosis: score of 7-10; I, intermediate: score of 4-6; N, normal: score of 0-3 
TABLE 2:  ASSOCIATIONS BETWEEN BACTERIAL VAGINOSIS AND PRESENCE OF OTHER MICRO-ORGANISMS   
  CHARACTERISTIC    VAGINAL FLORA MORPHOLOGY 
    n (%) BV (%) I (%) N (%) 
Trichomanas vaginalis* Positive 11 (3.7) 5 (45.5) 4 (36.4) 2 (18.2) 
  Negative 285 (96.3) 48 (16.8) 78 (27.4) 159 (55.8) 
            
Yeasts Positive 83 (28) 10 (12) 20 (24.1) 53 (63.9) 
  Negative 213 (72) 43 (20.2) 62 (29) 108 (50.7) 
                  
BV, bacterial vaginosis: score of 7-10; I, intermediate: score of 4-6; N, normal:score of 0-3. 
* P < 0.05; **  P < 0.01; *** P < 0.001  BV vs. I+N 
 
TABLE 3:  CORRELATIONS OF SYMPTOMS WITH LABORATORY DIAGNOSIS, NUMBERS IN PARENTHESES ARE 
PERCENTAGE OF CASES IN THE SAME ROW 
LABORATORY 
DIAGNOSIS 
SYMPTOM N (%) 





Normal  flora 20 (33.3) 22 (36.7) 13 (21.7) 5 (8.3) 60 
Bacterial vaginosis 6 (42.9) 2 (14.3) 5 (35.7) 1 (7.1) 14 
Yeats 12 (36.4) 12 (36.4) 7 (21.2) 2 (6.1) 33 
Trichomona vaginalis 2 (66.7) 1 (33.3) _ _ 3 
Mixed infection 6 (85.7) _ 1 (14.3) _ 7 





TABLE 4:  SENSITIVITY, SPECIFICITY AND POSITIVE PREDICTIVE VALUE OF SYMPTOMS AND SIGNS ASSOCIATED 
WITH BACTERIAL VAGINOSIS BY NUGENT SCORE. 
TEST N OF THE RESULT WITH THE 
FOLLOWING RESULT (N=117) 
SENSITIVITY SPECIFICITY PPV P VALUE 
TP FP TN FN (%) (%) (%) 
Vaginal discharge 19 34 62 9 57.1 65.2 26 NS 
Clue cells > 20% 12 2 94 2 90.4 97.7 90.4 < 0.001 
 
 TP, true positive; FP, false positive; TN, true negative; FN, false negative; PPV, positive predictive value; NS, not significant 
Discussion 
Bacterial vaginosis is not a new syndrome but 
rather an infection that is being increasingly 
recognized in most of developed countries but 
still under-recognized condition in many low 
settings. There have been no reports of the 
prevalence of bacterial vaginosis in Rwanda. 
The present study, which is a cross-sectional 
laboratory-based study to define the presence of 
vaginal infections, provided unique information 
on the prevalence of bacterial vaginosis in the 
symptomatic women in the developing 
community. 
In the present study our finding, with the 
overall prevalence of bacterial vaginosis of 
17.8%, is in agreement with most of the studies 
that showed different rates ranging from 17% to 
37% (11-13). However, higher rates of bacterial 
vaginosis have been reported in some studies 
carried out in developing countries. In a study 
from Haryama, India, bacterial vaginosis was 
diagnosed in a high percentage (48.5%) of rural 
women (14). These variations in the rate could 
be related to geographical distribution or 
systematic differences in the various population 
samples. The contrasting prevalence figures may 
be because of various reasons such as 
differences in socio-economic status, educational 
level and method used for diagnosis of bacterial 
vaginosis.    
Prevoius studies have found that bacterial 
vaginosis prevalence increased with age (15-17). 
In these studies, bacterial vaginosis prevalence 
was higher in women aged 25 years and older 
compared to women aged 14-24 years.  
 
However, another study showed no association 
between bacterial vaginosis and age > 25 years 
(11). Although our findings showed that the 
prevalence of bacterial vaginosis is lower among 
women 16-20 years of age, there is no evidence 
to support this assertion as number of women in 
this group of age was very few.  
 
In the present study, there were significant 
association of bacterial vaginosis with the 
presence of Trichomonas vaginalis in wet mount 
whereas no association was found with the 
presence of yeast on gram stain. The association 
of trichomoniasis with abnormal vaginal 
161 
 
ecology has been described by other authors (18, 
19).The prevalence of this organism rise 
gradually with a decrease in the normal 
bacterial flora. This can be explained in 2 
different ways: a normal vaginal ecology (score 
0-3) may inhibit infection with T. vaginalis or 
trichomoniasis may change the vaginal ecology, 
causing it to resemble bacterial vaginosis. As 
found in a study (19) the presence of yeast on 
gram stain was inversely related to the level of 
ecological disturbance. This support the view 
that the bacterial vaginosis environment is not 
conducive to yeast multiplication, and yeast 
vaginitis therefore does not occur in the 
presence of bacterial vaginosis. 
Out of 117 women with documented clinical 
information, the common symptom found was 
vaginal discharge in 39.3% followed by prurutis 
31.6% and lower abdominal pain 6.8%.  Clinical 
assessment is traditionally used for diagnosis. 
However, in the present study, none of the 
symptoms could significantly be attributed to a 
given infectious agent. A number of studies 
explored the association of vaginal discharge 
with vaginal infections (20, 21). With regard to 
clinical manifestations of vaginal infections 
among symptomatic women, all these studies 
found a variable degree of association between 
complaint of vaginal discharge and vaginal 
infections. Although these symptoms are not 
reliable, they are described in textbooks, as aids 
for the clinician to make a diagnosis of vaginal 
infection and to help choosing the proper 
medication. Even in our study, in more than 
33.3% of cases with a laboratory diagnosis of 
normal flora, vaginal discharge was present.  
Clue cells in wet mount were found to be 
significantly associated with bacterial vaginosis 
as shown by its sensitivity and positive 
predictive value. Our findings for positive clue 
cells also support previous studies that found it 
to have the highest sensitivity and specificity of 
the individual clinical criteria for diagnosing 
bacterial vaginosis (7, 22).   
In conclusion, bacterial vaginosis is common 
among women with vaginal symptoms in 
Rwanda as showed by its diagnosis using gram 
stain. In fact, the prevalence of women with 
bacterial vaginosis in our study compared 
favourably with a lot of studies, but is different 
from some of the reports mostly from 
developing country where high rates prevail(12, 
14).  Clue cells in wet mount are valuable aid in 
bacterial vaginosis diagnosis. Although we did 
not evaluate the association of symptoms with 
vaginal infection in this study directly, our data 
suggest that the current approach to the 
diagnosis of vaginal infection should be 
reconsidered. Further research with larger 
sample size targeting both symptomatic and 
asymptomatic women in Rwanda is needed to 
study vaginal infections. 
 
Acknowledgements 
We thank Marc Twagirumukiza (MD, PhD 
fellow in Clinical Pharmacology) for statistical 
analysis and constructive review, and all 





1. Hart G. Factors associated with 
trichomoniasis, candidiasis and bacterial 
vaginosis. Int J STD AIDS 1993;4(1):21-5. 
2. Goldenberg RL, Klebanoff MA, Nugent 
R, Krohn MA, Hillier S, Andrews WW.      
Bacterial colonization of the vagina 
during pregnancy in four ethnic groups. 
Vaginal Infections and Prematurity 
Study Group. Am J Obstet Gynecol 
1996;174(5):1618-21. 
3. Hill LH, Ruparelia H, Embil JA. 
Nonspecific vaginitis and other genital 
infections in three clinic populations. 
Sex Transm Dis 1983;10(3):114-8. 
4. van De Wijgert JH, Mason PR, 
Gwanzura L, Mbizvo MT, Chirenje ZM, 
Iliff V, et al. Intravaginal practices, 
vaginal flora disturbances, and 
acquisition of sexually transmitted 
diseases in Zimbabwean women. J Infect 
Dis 2000;181(2):587-94. 
5. Hillier SL. Diagnostic microbiology of 
bacterial vaginosis. Am J Obstet Gynecol 
1993;169(2 Pt 2):455-9. 
6. Hillier SL, Krohn MA, Klebanoff SJ, 
Eschenbach DA. The relationship of 
hydrogen peroxide-producing 
lactobacilli to bacterial vaginosis and 
genital microflora in pregnant women. 
Obstet Gynecol 1992;79(3):369-73. 
7. Amsel R, Totten PA, Spiegel CA, Chen 
KC, Eschenbach D, Holmes KK. 
Nonspecific vaginitis. Diagnostic criteria 
and microbial and epidemiologic 
associations. Am J Med 1983;74(1):14-22. 
8. Nugent RP, Krohn MA, Hillier SL. 
Reliability of diagnosing bacterial 
vaginosis is improved by a standardized 
method of gram stain interpretation. J 
Clin Microbiol 1991;29(2):297-301. 
9. Langsford MJ, Dobbs FF, Morrison GM, 
Dance DA. The effect of introduction of 
a guideline on the management of 
vaginal discharge and in particular 
bacterial vaginosis in primary care. Fam 
Pract 2001;18(3):253-7. 
10. Fleury FJ. Adult vaginitis. Clin Obstet 
Gynecol 1981;24(2):407-38. 
11. Bhalla P, Chawla R, Garg S, Singh MM, 
Raina U, Bhalla R, et al. Prevalence of 
bacterial vaginosis among women in 
Delhi, India. Indian J Med Res 
2007;125(2):167-72. 
12. Rao PS, Devi S, Shriyan A, Rajaram M, 
Jagdishchandra K. Diagnosis of bacterial 
vaginosis in a rural setup: Comparison 
of clinical algorithm, smear scoring and 
culture by semiquantitative technique. 
Indian J Med Microbiol 2004;22(1):47-50. 
13. Kharsany AB, Hoosen AA, Moodley J. 
Bacterial vaginosis and lower genital 
tract infections in women attending out-
patient clinics at a tertiary institution 
serving a developing community. J 
Obstet Gynaecol 1997;17(2):171-5. 
14. Aggarwal AK, Kumar R, Gupta V, 
Sharma M. Community based study of 
reproductive tract infections among ever 
163 
 
married women of reproductive age in a 
rural area of Haryana, India. J Commun 
Dis 1999;31(4):223-8. 
15. Moi H. Prevalence of bacterial vaginosis 
and its association with genital 
infections, inflammation, and 
contraceptive methods in women 
attending sexually transmitted disease 
and primary health clinics. Int J STD 
AIDS 1990;1(2):86-94. 
16. Sewankambo N, Gray RH, Wawer MJ, 
Paxton L, McNaim D, Wabwire-Mangen 
F, et al. HIV-1 infection associated with 
abnormal vaginal flora morphology and 
bacterial vaginosis. Lancet 
1997;350(9077):546-50. 
17. Allsworth JE, Peipert JF. Prevalence of 
bacterial vaginosis: 2001-2004 National 
Health and Nutrition Examination 
Survey data. Obstet Gynecol 
2007;109(1):114-20. 
18. Franklin TL, Monif GR. Trichomonas 
vaginalis and bacterial vaginosis. 
Coexistence in vaginal wet mount 
preparations from pregnant women. J 
Reprod Med 2000;45(2):131-4. 
19. Moodley P, Connolly C, Sturm AW. 
Interrelationships among human 
immunodeficiency virus type 1 
infection, bacterial vaginosis, 
trichomoniasis, and the presence of 
yeasts. J Infect Dis 2002;185(1):69-73. 
20. Bornstein J, Lakovsky Y, Lavi I, Bar-Am 
A, Abramovici H. The classic approach 
to diagnosis of vulvovaginitis: a critical 
analysis. Infect Dis Obstet Gynecol 
2001;9(2):105-11. 
21. Shobeiri F, Nazari M. A prospective 
study of genital infections in Hamedan, 
Iran. Southeast Asian J Trop Med Public 
Health 2006;37 Suppl 3:174-7. 
22. Gutman RE, Peipert JF, Weitzen S, 
Blume J. Evaluation of clinical methods 
for diagnosing bacterial vaginosis. 






Visit our website:  http//www.ajol.info/journals/ajcem 
 
 
 
 
 
 
 
